| Regulatory Roundup: FDA news on omecamtiv mecarbil for HFrEF, 'world's smallest heart pump' and more |
| Patients with especially high blood pressure may want to limit how much coffee they drink |
| VIDEO: The importance of assessing TAVR valve durability |
| VIDEO: Identifying cardiotoxicity in young cancer patients |
| FDA announces recall of intra-aortic balloon pumps due to risk of cardiac arrest, stroke or death |
| VIDEO: The need to develop the cardiology workforce |
| Black stroke patients hospitalized longer than white patients |
| How cardiologists can fight back against misinformation |
| AI specialists ink deal with Pfizer to target cardiac amyloidosis |
| New discovery could reduce the risk of heart damage among cancer patients |
| No antithrombotic therapy after TAVR? New research highlights potential benefits |
| Why is heart failure so common among Hispanic patients? Researchers receive $5.2M to test a new theory |
| Cardiologists explore the real-world potential of new adjustable stents for children |
| World’s leading cardiology groups say it is time to rethink RCTs |
| Cardiologist the subject of several malpractice claims for allegedly performing unnecessary heart operations |
| Corindus, acquired back in 2019, is now Siemens Healthineers Endovascular Robotics |
| Mike Gabler, a heart valve specialist with Edwards Lifesciences, wins Survivor—and donates his $1M prize |
| Northwestern Medicine opens advanced outpatient cardiac clinic at suburban Chicago |
| VIDEO: 2 key technologies to rapidly advance cardiovascular care |
| Cardiovascular disease still the No. 1 cause of death in the world |
| COVID-19 infection and vaccination linked to debilitating heart condition—risk from vaccines ‘relatively slim’ |
| Boston Scientific to acquire majority stake of interventional device company for $523M |
| How cardiologists can steer patient discussions about costs and value in the right direction |
| New risk score helps identify high-risk PCI patients |
| Treatments for rheumatoid arthritis, Parkinson’s disease linked to cardiovascular benefits |
| AI-powered platform for heart failure detection gains FDA clearance |
| Cardiologists fear new regulations will cause a medical device shortage in Europe |
| Alternative therapies for heart failure: Health experts detail the good, the bad and the unknown |
| Interventional cardiology to join the Match in 2025 |
| An updated look at the latest self-expandable and balloon-expandable TAVR devices |
| Most devices implanted during LAAO procedures are oversized—and patients benefit |
| DASH diet reduces long-term risk of heart disease |
| New ‘ultra-soft’ wearable device uses ECG, SCG results to monitor heart health |
| FDA changes indications for Impella RP heart pump after dramatic shift in mortality rate |
| Medtronic reaches milestone in study of pulsed-field ablation and mapping catheter for AFib |
| Seaweed molecules could lead to big improvements for heart surgery patients |
| Supply chain problems: FDA warns of new shortage of intra-aortic balloon pumps, catheters and spare parts |
| FDA announces another recall for troubled heart device after multiple hospitalizations |
| Boston Scientific's new TAVR system associated with high success rate, low mortality rate |
| High copays keep many heart failure patients from filling needed prescriptions |
| Cardiologist urges physicians to promote plant-based diets: ‘We owe it to the profession, our patients and the planet’ |
